Skip to search formSkip to main contentSkip to account menu

HYPOMYELINATION AND CONGENITAL CATARACT

Known as: HLD5, HYPOMYELINATION AND CONGENITAL CATARACT: HCC, LEUKODYSTROPHY, HYPOMYELINATING, 5 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Resection and radiofrequency ablation (RFA) are treatment options for hepatocellular carcinoma (HCC) <3 cm; there is interest in… 
Review
2014
Review
2014
PURPOSE To compare the long-term therapeutic outcomes of radiofrequency (RF) ablation for small perivascular hepatocellular… 
Highly Cited
2011
Highly Cited
2011
Glypican 3 (GPC3) is a valuable diagnostic marker and a potential therapeutic target in hepatocellular carcinoma (HCC). To… 
Highly Cited
2011
Highly Cited
2011
Anti‐angiogenesis agents have shown effectiveness in treatment of hepatocellular carcinoma (HCC). It is important to investigate… 
Highly Cited
2011
Highly Cited
2011
BackgroundThe impact of viral factors on the prognosis of hepatocellular carcinoma (HCC) remains controversial because of… 
Highly Cited
2010
Highly Cited
2010
Genetic polymorphisms in DNA repair genes may influence individual variations in DNA repair capacity, and this may be associated… 
Highly Cited
2002
Highly Cited
2002
HYPOTHESIS Transarterial chemoembolization (TACE) is beneficial for selected patients with unresectable hepatocellular carcinoma… 
Highly Cited
1998
Highly Cited
1998
OBJECTIVE The objective of this study from the International Registry of Hepatic Tumors in Liver Transplantation is to analyze… 
Highly Cited
1995
Highly Cited
1995
To assess the differences in the surgical results between patients with hepatitis B‐ and hepatitis C‐related hepatocellular…